Nutraceuticals CDMO Segmented by End-user Industry and Geography - Growth, Trends, and Forecast (2025 - 2035)

The global Nutraceuticals CDMO market size was valued at USD 42.60 Billion in 2025 and is projected to grow from USD 46.80 Billion in 2026 to USD 118.40 Billion by 2035, at a CAGR of 10.9% from 2026 to 2035. North America dominated the market, accounting for the largest revenue share of 34.2% in 2025. The global market is driven by brand owners outsourcing manufacturing to concentrate capital on formulation and marketing rather than plant ownership, portfolio consolidation among large CDMOs sharpening focus on core nutraceutical capabilities, private-equity capital entering dedicated nutraceutical manufacturing assets, and rising dosage-form complexity pushing brand owners toward specialist contract manufacturers.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.co....m/request-free-sampl